|
| 36805919 | Older age should not be a barrier to testing for somatic variants in homologous recombination DNA repair-related genes in patients with high-grade serous ovarian carcinoma. | Transl Oncol | 2023 |
| 36805919 | Older age should not be a barrier to testing for somatic variants in homologous recombination DNA repair-related genes in patients with high-grade serous ovarian carcinoma. | Transl Oncol | 2023 |
| 34636747 | New therapeutic opportunities for women with low-grade serous ovarian cancer. | Endocr Relat Cancer | 2021 |
| 33751322 | Interobserver concordance in visual assessment of Ki67 immunohistochemistry in surgical excision specimens from patients with lymph node-negative breast cancer. | Breast Cancer Res Treat | 2021 |
| 34636747 | New therapeutic opportunities for women with low-grade serous ovarian cancer. | Endocr Relat Cancer | 2021 |
| 33751322 | Interobserver concordance in visual assessment of Ki67 immunohistochemistry in surgical excision specimens from patients with lymph node-negative breast cancer. | Breast Cancer Res Treat | 2021 |
| 32732981 | Strategies to enable large-scale proteomics for reproducible research. | Nat Commun | 2020 |
| 32732981 | Strategies to enable large-scale proteomics for reproducible research. | Nat Commun | 2020 |
| 30444966 | Accelerated Barocycler Lysis and Extraction Sample Preparation for Clinical Proteomics by Mass Spectrometry. | J Proteome Res | 2019 |
| 30444966 | Accelerated Barocycler Lysis and Extraction Sample Preparation for Clinical Proteomics by Mass Spectrometry. | J Proteome Res | 2019 |
| 31082762 | Tamoxifen-induced severe hot flashes and endoxifen levels: is dose reduction a safe and effective strategy? | Breast | 2019 |
| 31321850 | Addressing the Challenges of High-Throughput Cancer Tissue Proteomics for Clinical Application: ProCan. | Proteomics | 2019 |
| 31321850 | Addressing the Challenges of High-Throughput Cancer Tissue Proteomics for Clinical Application: ProCan. | Proteomics | 2019 |
| 31082762 | Tamoxifen-induced severe hot flashes and endoxifen levels: is dose reduction a safe and effective strategy? | Breast | 2019 |
| 29214365 | Profiling differential microRNA expression between in situ, infiltrative and lympho-vascular space invasive breast cancer: a pilot study. | Clin Exp Metastasis | 2018 |
| 35135122 | <i>BRAF</i> Mutations in Low-Grade Serous Ovarian Cancer and Response to BRAF Inhibition. | JCO Precis Oncol | 2018 |
| 29214365 | Profiling differential microRNA expression between in situ, infiltrative and lympho-vascular space invasive breast cancer: a pilot study. | Clin Exp Metastasis | 2018 |
| 29367611 | Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer. | Sci Rep | 2018 |
| 35135122 | <i>BRAF</i> Mutations in Low-Grade Serous Ovarian Cancer and Response to BRAF Inhibition. | JCO Precis Oncol | 2018 |
| 29367611 | Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer. | Sci Rep | 2018 |
| 25940428 | No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer. | Gynecol Oncol | 2016 |
| 25940428 | No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer. | Gynecol Oncol | 2016 |
| 26847054 | Dose Escalation of Tamoxifen in Patients with Low Endoxifen Level: Evidence for Therapeutic Drug Monitoring-The TADE Study. | Clin Cancer Res | 2016 |
| 27444035 | Serous ovarian and primary peritoneal cancers: A comparative analysis of clinico-pathological features, molecular subtypes and treatment outcome. | Gynecol Oncol | 2016 |
| 27444035 | Serous ovarian and primary peritoneal cancers: A comparative analysis of clinico-pathological features, molecular subtypes and treatment outcome. | Gynecol Oncol | 2016 |
| 26847054 | Dose Escalation of Tamoxifen in Patients with Low Endoxifen Level: Evidence for Therapeutic Drug Monitoring-The TADE Study. | Clin Cancer Res | 2016 |
| 25897948 | Common germline polymorphisms associated with breast cancer-specific survival. | Breast Cancer Res | 2015 |
| 25897948 | Common germline polymorphisms associated with breast cancer-specific survival. | Breast Cancer Res | 2015 |
| 25855707 | Prediction of breast cancer risk based on profiling with common genetic variants. | J Natl Cancer Inst | 2015 |
| 25890600 | Identification of novel genetic markers of breast cancer survival. | J Natl Cancer Inst | 2015 |
| 25890600 | Identification of novel genetic markers of breast cancer survival. | J Natl Cancer Inst | 2015 |
| 25855707 | Prediction of breast cancer risk based on profiling with common genetic variants. | J Natl Cancer Inst | 2015 |
| 24403187 | The prognostic value of Ki67 in systemically untreated patients with node-negative breast cancer. | J Clin Pathol | 2014 |
| 25316818 | Genomic classification of serous ovarian cancer with adjacent borderline differentiates RAS pathway and TP53-mutant tumors and identifies NRAS as an oncogenic driver. | Clin Cancer Res | 2014 |
| 25857409 | Refined histopathological predictors of BRCA1 and BRCA2 mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia. | Breast Cancer Res | 2014 |
| 24403187 | The prognostic value of Ki67 in systemically untreated patients with node-negative breast cancer. | J Clin Pathol | 2014 |
| 24810093 | Paclitaxel sensitivity in relation to ABCB1 expression, efflux and single nucleotide polymorphisms in ovarian cancer. | Sci Rep | 2014 |
| 24927736 | Genetic variation in mitotic regulatory pathway genes is associated with breast tumor grade. | Hum Mol Genet | 2014 |
| 25857409 | Refined histopathological predictors of BRCA1 and BRCA2 mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia. | Breast Cancer Res | 2014 |
| 25316818 | Genomic classification of serous ovarian cancer with adjacent borderline differentiates RAS pathway and TP53-mutant tumors and identifies NRAS as an oncogenic driver. | Clin Cancer Res | 2014 |
| 24810093 | Paclitaxel sensitivity in relation to ABCB1 expression, efflux and single nucleotide polymorphisms in ovarian cancer. | Sci Rep | 2014 |
| 24927736 | Genetic variation in mitotic regulatory pathway genes is associated with breast tumor grade. | Hum Mol Genet | 2014 |
| 23535733 | Genome-wide association studies identify four ER negative-specific breast cancer risk loci. | Nat Genet | 2013 |
| 24247619 | Prohibitin expression is associated with high grade breast cancer but is not a driver of amplification at 17q21.33. | Pathology | 2013 |
| 23436927 | Ki67 and proliferation in breast cancer. | J Clin Pathol | 2013 |
| 23535733 | Genome-wide association studies identify four ER negative-specific breast cancer risk loci. | Nat Genet | 2013 |
| 24247619 | Prohibitin expression is associated with high grade breast cancer but is not a driver of amplification at 17q21.33. | Pathology | 2013 |
| 23436927 | Ki67 and proliferation in breast cancer. | J Clin Pathol | 2013 |
| 21331789 | Development of a data entry auditing protocol and quality assurance for a tissue bank database. | Cell Tissue Bank | 2012 |
| 22812573 | High-risk estrogen-receptor-positive breast cancer: identification and implications for therapy. | Mol Diagn Ther | 2012 |